CryoCath Technologies
Kirkland, Quebec, Canada
About CryoCath Technologies
CryoCath Technologies develops, manufactures, and markets cryoablation catheter systems for the treatment of cardiac arrhythmias, tumours and other obstructions in the body. These systems comprise flexible, steerable catheters that are supported by electromechanical consoles that deliver and recover refrigerants from the catheters that are placed in the body through minimally-invasive means. The key offerings of CryoCath include electrophysiology products such as Achieve Mapping Catheter, Arctic Front and FlexCath, The CryoConsole, Freezor, Freezor MAX, and Freezor Xtra. The company offers its products through distributors in the regions of Europe, North America, Middle East and the Russian Federation. Currently, CryoCath Technologies operates as a subsidiary of Medtronic, Inc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Series B (Feb 1998)
- Website: cryocath.com
Industries & Categories
Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/cryocath-technologies-2546026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.